Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

725 trials with published results (16%)

Research Maturity

2840 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.8%

219 terminated out of 4543 trials

Success Rate

92.8%

+6.3% vs benchmark

Late-Stage Pipeline

9%

429 trials in Phase 3/4

Results Transparency

26%

725 of 2840 completed with results

Key Signals

725 with results93% success219 terminated

Data Visualizations

Phase Distribution

3,876Total
Not Applicable (2908)
Early P 1 (43)
P 1 (193)
P 2 (303)
P 3 (168)
P 4 (261)

Trial Status

Completed2,840
Unknown546
Recruiting471
Terminated219
Not Yet Recruiting156
Active Not Recruiting127

Trial Success Rate

92.8%

Benchmark: 86.5%

Based on 2840 completed trials

Clinical Trials (4543)

Showing 20 of 20 trials
NCT07737366Not ApplicableCompleted

The Efficacy of Lavender Herbal Tea in Premenstrual Syndrome

NCT07336238Phase 2Active Not Recruiting

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

NCT07149428Enrolling By Invitation

Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)

NCT07413874Not ApplicableRecruiting

Telehealth Music Therapy for Adults With Endocrine Disorder and Depression

NCT06472726Not ApplicableTerminated

Mental Health App for Cancer Survivors Study

NCT07737652Not ApplicableCompletedPrimary

Microcurrent Neurofeedback as an Adjunct to Standard Care for Substance Use Disorders

NCT07736508Not ApplicableNot Yet RecruitingPrimary

Systemic Couple Therapy for Marital Dynamics and Mental Health

NCT06801041Phase 2RecruitingPrimary

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

NCT07714889Not ApplicableWithdrawn

Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID

NCT04201106Not ApplicableTerminatedPrimary

A Neuroimaging Study of Open-label Placebo in Depressed Adolescents

NCT06039930Not ApplicableRecruitingPrimary

Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation

NCT06567340Not ApplicableRecruitingPrimary

StratCare Trial 2: Evaluating the Clinical and Cost-effectiveness of AI-driven Stratified Care for Depression

NCT07692269Not ApplicableRecruiting

Mindfulness Intervention for Emotional Distress: An EEG Study

NCT00024635Recruiting

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers

NCT00044174CompletedPrimary

Dyadic Interactions in Depressed and Non-Depressed Mothers and Their Infants

NCT04524767Not ApplicableCompletedPrimary

Depression Screening in Black Churches

NCT02543983Phase 2Recruiting

Neurobiology of Suicide

NCT05044546Not ApplicableActive Not RecruitingPrimary

A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers

NCT04777357Phase 3RecruitingPrimary

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

NCT01816152Not ApplicableCompleted

Methodology Issues in a Tailored Light Treatment for Persons With Dementia

Scroll to load more

Research Network

Activity Timeline